Posts Tagged ‘anticoagulant’
Stephan Moll, MD writes… Another ‘blood thinner’ medication is now under consideration by the FDA for the treatment of DVT and PE.
On Dec 19th the FDA accepted the application by Bristol-Myers Squibb (BMS) and Pfizer for review of Eliquis (apixaban) for the treatment of DVT and PE and for the reduction in the risk of recurrent DVT and PE. The goal date for a decision by the FDA is August 25, 2014. The press release about this submission from BMS is here. Read the rest of this entry »
Beth Waldron, Clot Connect Program Director and Stephan Moll, MD, Clot Connect Medical Director write….
Patients who have ended their recommended course of prescription anticoagulation treatment are understandably concerned about a clot recurrence and will ask “is there anything I can do to prevent a future clot?” Some have heard from friends or the internet that a particular herb, vitamin, or food will aid in the prevention of DVT and PE.
Since more than half of adults in the United States take a dietary supplement of some kind, it may be helpful to examine the science behind some of the most common natural supplements and foods said to prevent blood clots. Read the rest of this entry »
Beth Waldron and Stephan Moll, MD write….
While much is known about blood clots and clotting disorders, there is still much being learnt. Medical information changes over time as new clinical trials, research studies and evidence-based guidelines contribute to knowledge of and treatments for blood clots and clotting disorders. Many of today’s standards of treatment are based upon what was learned from publications in the past.
Over the past year, a number of publications emerged which will influence future clinical decisions and potentially impact your care. Here is a summary of the ‘top clinically relevant publications from 2012’ and how they may affect you. Read the rest of this entry »
“I am on warfarin (Coumadin®). Can I donate blood?” No. A person on a blood thinner (anticoagulant), like warfarin, will not be accepted as a blood donor Read the rest of this entry »
“Is generic Arixtra as safe and effective as brand Arixtra?” a patient asks. Answer: Yes.
Generic fondaparinux made by Dr. Reddy’s Laboratories Ltd. was approved by the FDA on July 11, 2011 Read the rest of this entry »
Beth Waldron, Program Director of the Clot Connect project, writes….
Approximately 1 in 5 people don’t take a medication a doctor has prescribed because they can’t afford to pay for it [ref 1]. While the cost of some outpatient “blood thinning” therapies (anticoagulants) can be substantial, failure to take a blood thinning medication as prescribed can have serious, even deadly, consequences.
What can you do when prescribed a blood thinner you cannot afford? Read the rest of this entry »
Stephan Moll writes…
Savaysa® (Edoxaban), the 4th of the big new oral blood thinners in development (the other big 3 being Dabigatran = Pradaxa, Rivaroxaban = Xarelto, and Apixaban = Eliquis), is now commercially available in Japan (July 19th, 2011 press release here). It is available as once daily dosing for prevention of blood clots in the legs and lungs (DVT and PE) Read the rest of this entry »
Eliquis (Apixaban) is one of the 4 promising new oral “blood thinners” that (a) do not require monitoring of its “blood thinning” (anticoagulant) effect, i.e. do not require INR monitoring, and (b) do not interfere with vitamin K in the diet, i.e. patients can eat what they want. Read the rest of this entry »
Stephan Moll, MD writes…
What Kind of Clot did You Have?
If you have had a blood clot in your legs or your lung (pulmonary embolism=PE), you will wonder how long you should stay on a “blood thinner”. The decision depends on a number of factors which will be discussed below. Read the rest of this entry »
A major study published in December 2010 in the prestigious New England Journal of Medicine (NEJM) shows that the new oral “blood thinner” Xarelto® (=Rivaroxaban) is (a) as safe and effective as warfarin in patients with acute deep vein thrombosis (DVT), and (b) is quite effective in preventing recurrent blood clots (DVT and pulmonary embolism=PE) if taken longer-term, Read the rest of this entry »